A randomized, double‐blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: Short‐ and long‐term efficacy and safety resultsNicolino Ruperto, Stefan Simianer, И. П. Никишина et al.|Arthritis & Rheumatism|2005Cited by 97
<i>EXTL3</i> mutations cause skeletal dysplasia, immune deficiency, and developmental delayStefano Volpi, Luigi D. Notarangelo, Yasuhiro Yamazaki et al.|The Journal of Experimental Medicine|2017Cited by 86
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trialIris Vilca, Nicolino Ruperto, Christian Huemer et al.|Annals of the Rheumatic Diseases|2010Cited by 63
Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.Angelo Ravelli, Alberto Martini, V. Gerloni et al.|PubMed|1998Cited by 24
ANTINUCLEAR ANTIBODY POSITIVITY IS THE BEST PREDICTOR OF RESPONSE TO METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITIS. ANALYSIS OF THE PRINTO TRIALPaula García, Nicolino Ruperto, Angelo Ravelli et al.|JCR Journal of Clinical Rheumatology|2006Cited by 1